Back
Agios Pharmaceuticals Vs. Blueprint Medicines Industry Stock Comparison
Sell
48
AGIO
Agios Pharmaceuticals
Last Price:
34.54
Seasonality Move:
2.19%
Buy
71
BPMC
Blueprint Medicines
Last Price:
107.20
Seasonality Move:
11.38%
Sell
48
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $34.54. The Score for AGIO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
- The current Blueprint Medicines [BPMC] share price is $107.19. The Score for BPMC is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- BPMC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $34.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AGIO is experiencing slight selling pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $107.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.
AGIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.23 | Buy |
Relative Strength Index (14 RSI): | 74.3 | Buy |
Chaikin Money Flow: | -13101 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.39 - 32.41) | Buy |
Bollinger Bands (100): | (23.2 - 31.1) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.9 | Buy |
Relative Strength Index (14 RSI): | 72.5 | Buy |
Chaikin Money Flow: | -534550 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (87.11 - 97.27) | Buy |
Bollinger Bands (100): | (81.46 - 93.76) | Buy |
AGIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.86 | Buy |
20-day SMA: | 30.92 | Buy |
50-day SMA: | 30.69 | Buy |
200-day SMA: | 25.72 | Buy |
8-day EMA: | 33.02 | Buy |
20-day EMA: | 31.54 | Buy |
50-day EMA: | 29.92 | Buy |
200-day EMA: | 26.86 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 96.19 | Buy |
20-day SMA: | 92.09 | Buy |
50-day SMA: | 91.67 | Buy |
200-day SMA: | 71.37 | Buy |
8-day EMA: | 98.07 | Buy |
20-day EMA: | 93.99 | Buy |
50-day EMA: | 90.64 | Buy |
200-day EMA: | 76.5 | Buy |
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.12 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.10 per share, an increase next quarter of $0.40 per share, an increase this year of $4.41 per share, and an increase next year of $1.64 per share.
Agios Pharmaceuticals Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |